In the words of Cleveland HeartLab CEO Jake Orville, business has “exploded” since the beginning of the year, just months after his company launched a proprietary test for cardiac inflammation under a ...

Biomarker test-maker Cleveland HeartLab has closed an $18.4 million series B round of funding, which was led by two Boston-area investors. The size of the round is a testament to the explosive growth ...

Cleveland HeartLab Inc. has secured an $18.4 million investment that will help the company expand its employee base, its product lineup and its physical footprint in Cleveland, said CEO Jake Orville.

Cleveland HeartLab has agreed to be acquired by Quest Diagnostics, a Fortune 500 medical testing company based in New Jersey. The deal should help the Cleveland Clinic spinout company accelerate its ...

A Cleveland Clinic spinoff company formed in late 2009 as the newest entry in the field of cardiovascular technology is now poised for more growth. Cleveland HeartLab president and chief executive ...

CLEVELAND, Ohio -- For decades, doctors have been putting tens of millions of Americans on drugs that lower their blood pressure and cholesterol. They have good reason to, experts say. People with ...

Licensed from the Cleveland Clinic, TMAO has received widespread scientific and public attention since its discovery. In 2013, the American Heart Association and the American Stroke Association ...

Cleveland HeartLab is continuing what MedCity News is calling "explosive growth" for the biomarker test-maker since it was spun out of the Cleveland Clinic less than two years ago. The company just ...

CLEVELAND--(BUSINESS WIRE)-- Cleveland HeartLab Inc. (CHL), a leading specialty clinical laboratory and disease management company, today announced the completion of an $18.4-million Series B ...

New Zealand-based medtech startup HeartLab has raised $2.45 million in seed funding that it says will help the company expand its AI-powered heart scanning and reporting platform to cardiologists in ...